Aurora Investment Counsel’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Sell
34,744
-892
-3% -$59.4K 1.2% 25
2026
Q1
$2.24M Sell
35,636
-1,029
-3% -$71.7K 1.24% 26
2025
Q4
$2.43M Buy
36,665
+2,671
+8% +$173K 1.28% 29
2025
Q3
$2.29M Buy
+33,994
New +$2.69M 1.2% 31

Other funds holding DXCM

Aurora Investment Counsel's DXCM Position: Q2 2026 in Review

Aurora Investment Counsel reduced its DexCom (DXCM) stake by 2.5% in Q2 2026, selling an estimated $59.4K and leaving 34,744 shares worth $2.34M. The position accounts for 1.2% of the portfolio, ranked #25.

Aurora Investment Counsel first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.43M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Aurora Investment Counsel held 34,744 shares of DexCom worth $2.34M as of Q2 2026.
  • Aurora Investment Counsel sold 892 DexCom shares in Q2 2026, an estimated $59.4K.
  • DexCom made up 1.2% of Aurora Investment Counsel's portfolio in Q2 2026, its #25 holding.
  • Aurora Investment Counsel first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
  • Aurora Investment Counsel's DexCom position peaked at $2.43M in Q4 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.